Literature DB >> 32732131

RIPK protein kinase family: Atypical lives of typical kinases.

Gregory D Cuny1, Alexei Degterev2.   

Abstract

Receptor Interacting Protein Kinases (RIPKs) are a family of Ser/Thr/Tyr kinases whose functions, regulation and pathophysiologic roles have remained an enigma for a long time. In recent years, these proteins garnered significant interest due to their roles in regulating a variety of host defense functions including control of inflammatory gene expression, different forms of cell death, and cutaneous and intestinal barrier functions. In addition, there is accumulating evidence that while these kinases seemingly follow typical kinase blueprints, their functioning in cells can take forms that are atypical for protein kinases. Lastly, while these kinases generally belong to distinct areas of innate immune regulation, there are emerging overarching themes that may unify the functions of this kinase family. Our review seeks to discuss the biology of RIPKs, and how typical and atypical features of this family informs the activity of a rapidly growing repertoire of RIPK inhibitors.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  RIPK1; RIPK2; RIPK3; RIPK4; RIPK5; apoptosis; inflammation; kinase; necroptosis

Mesh:

Substances:

Year:  2020        PMID: 32732131      PMCID: PMC8286629          DOI: 10.1016/j.semcdb.2020.06.014

Source DB:  PubMed          Journal:  Semin Cell Dev Biol        ISSN: 1084-9521            Impact factor:   7.727


  136 in total

1.  RIP: a novel protein containing a death domain that interacts with Fas/APO-1 (CD95) in yeast and causes cell death.

Authors:  B Z Stanger; P Leder; T H Lee; E Kim; B Seed
Journal:  Cell       Date:  1995-05-19       Impact factor: 41.582

2.  RIP3 induces apoptosis independent of pronecrotic kinase activity.

Authors:  Pratyusha Mandal; Scott B Berger; Sirika Pillay; Kenta Moriwaki; Chunzi Huang; Hongyan Guo; John D Lich; Joshua Finger; Viera Kasparcova; Bart Votta; Michael Ouellette; Bryan W King; David Wisnoski; Ami S Lakdawala; Michael P DeMartino; Linda N Casillas; Pamela A Haile; Clark A Sehon; Robert W Marquis; Jason Upton; Lisa P Daley-Bauer; Linda Roback; Nancy Ramia; Cole M Dovey; Jan E Carette; Francis Ka-Ming Chan; John Bertin; Peter J Gough; Edward S Mocarski; William J Kaiser
Journal:  Mol Cell       Date:  2014-11-20       Impact factor: 17.970

3.  Disruption of XIAP-RIP2 Association Blocks NOD2-Mediated Inflammatory Signaling.

Authors:  Tatiana Goncharov; Stefanie Hedayati; Melinda M Mulvihill; Anita Izrael-Tomasevic; Kerry Zobel; Surinder Jeet; Anna V Fedorova; Celine Eidenschenk; Jason deVoss; Kebing Yu; Andrey S Shaw; Donald S Kirkpatrick; Wayne J Fairbrother; Kurt Deshayes; Domagoj Vucic
Journal:  Mol Cell       Date:  2018-02-15       Impact factor: 17.970

4.  Structure guided design of potent and selective ponatinib-based hybrid inhibitors for RIPK1.

Authors:  Malek Najjar; Chalada Suebsuwong; Soumya S Ray; Roshan J Thapa; Jenny L Maki; Shoko Nogusa; Saumil Shah; Danish Saleh; Peter J Gough; John Bertin; Junying Yuan; Siddharth Balachandran; Gregory D Cuny; Alexei Degterev
Journal:  Cell Rep       Date:  2015-03-24       Impact factor: 9.423

5.  A critical role of RICK/RIP2 polyubiquitination in Nod-induced NF-kappaB activation.

Authors:  Mizuho Hasegawa; Yukari Fujimoto; Peter C Lucas; Hiroyasu Nakano; Koichi Fukase; Gabriel Núñez; Naohiro Inohara
Journal:  EMBO J       Date:  2007-12-13       Impact factor: 11.598

6.  RIP4 (DIK/PKK), a novel member of the RIP kinase family, activates NF-kappa B and is processed during apoptosis.

Authors:  Etienne Meylan; Fabio Martinon; Margot Thome; Michael Gschwendt; Jürg Tschopp
Journal:  EMBO Rep       Date:  2002-11-21       Impact factor: 8.807

7.  The crystal structure of the catalytic domain of the NF-κB inducing kinase reveals a narrow but flexible active site.

Authors:  Gladys de Leon-Boenig; Krista K Bowman; Jianwen A Feng; Terry Crawford; Christine Everett; Yvonne Franke; Angela Oh; Mark Stanley; Steven T Staben; Melissa A Starovasnik; Heidi J A Wallweber; Jiansheng Wu; Lawren C Wu; Adam R Johnson; Sarah G Hymowitz
Journal:  Structure       Date:  2012-08-23       Impact factor: 5.006

8.  Discovery of 7-Oxo-2,4,5,7-tetrahydro-6 H-pyrazolo[3,4- c]pyridine Derivatives as Potent, Orally Available, and Brain-Penetrating Receptor Interacting Protein 1 (RIP1) Kinase Inhibitors: Analysis of Structure-Kinetic Relationships.

Authors:  Masato Yoshikawa; Morihisa Saitoh; Taisuke Katoh; Tomohiro Seki; Simone V Bigi; Yuji Shimizu; Tsuyoshi Ishii; Takuro Okai; Masako Kuno; Harumi Hattori; Etsuro Watanabe; Kumar S Saikatendu; Hua Zou; Masanori Nakakariya; Takayuki Tatamiya; Yoshihisa Nakada; Takatoshi Yogo
Journal:  J Med Chem       Date:  2018-03-06       Impact factor: 7.446

9.  Mutations in IRF6 cause Van der Woude and popliteal pterygium syndromes.

Authors:  Shinji Kondo; Brian C Schutte; Rebecca J Richardson; Bryan C Bjork; Alexandra S Knight; Yoriko Watanabe; Emma Howard; Renata L L Ferreira de Lima; Sandra Daack-Hirsch; Achim Sander; Donna M McDonald-McGinn; Elaine H Zackai; Edward J Lammer; Arthur S Aylsworth; Holly H Ardinger; Andrew C Lidral; Barbara R Pober; Lina Moreno; Mauricio Arcos-Burgos; Consuelo Valencia; Claude Houdayer; Michel Bahuau; Danilo Moretti-Ferreira; Antonio Richieri-Costa; Michael J Dixon; Jeffrey C Murray
Journal:  Nat Genet       Date:  2002-09-03       Impact factor: 38.330

Review 10.  NOD Signaling and Cell Death.

Authors:  Valentin J Heim; Che A Stafford; Ueli Nachbur
Journal:  Front Cell Dev Biol       Date:  2019-10-02
View more
  11 in total

Review 1.  Tumor-intrinsic and immune modulatory roles of receptor-interacting protein kinases.

Authors:  A Justin Rucker; Francis Ka-Ming Chan
Journal:  Trends Biochem Sci       Date:  2022-01-05       Impact factor: 13.807

2.  DSTYK inhibition increases the sensitivity of lung cancer cells to T cell-mediated cytotoxicity.

Authors:  Karmele Valencia; Mirari Echepare; Álvaro Teijeira; Andrea Pasquier; Cristina Bértolo; Cristina Sainz; Ibon Tamayo; Beñat Picabea; Graziella Bosco; Roman Thomas; Jackeline Agorreta; José María López-Picazo; Joan Frigola; Ramon Amat; Alfonso Calvo; Enriqueta Felip; Ignacio Melero; Luis M Montuenga
Journal:  J Exp Med       Date:  2022-09-28       Impact factor: 17.579

3.  Necroptosis-associated classification combined with tumor microenvironment characteristic analysis of cutaneous melanoma.

Authors:  Gang Hu; Yan Jiang; Jianying Ma; Hui Zhan
Journal:  Sci Rep       Date:  2022-05-24       Impact factor: 4.996

4.  Design of pyrido[2,3-d]pyrimidin-7-one inhibitors of receptor interacting protein kinase-2 (RIPK2) and nucleotide-binding oligomerization domain (NOD) cell signaling.

Authors:  Sameer Nikhar; Ioannis Siokas; Lisa Schlicher; Seungheon Lee; Mads Gyrd-Hansen; Alexei Degterev; Gregory D Cuny
Journal:  Eur J Med Chem       Date:  2021-02-03       Impact factor: 6.514

5.  Catecholamine Surges Cause Cardiomyocyte Necroptosis via a RIPK1-RIPK3-Dependent Pathway in Mice.

Authors:  Penglong Wu; Mingqi Cai; Jinbao Liu; Xuejun Wang
Journal:  Front Cardiovasc Med       Date:  2021-09-16

6.  Quyu Shengxin Decoction Alleviates DSS-Induced Ulcerative Colitis in Mice by Suppressing RIP1/RIP3/NLRP3 Signalling.

Authors:  Chuang Wu; Haojie Yang; Changpeng Han; Qingming Wang; Haiyan Zhang; Ting Huang; Wenjing Mao; Cheng Tang; Wenjun Zhao; Zhiming Zhu; Jing Xu; Wei Yang
Journal:  Evid Based Complement Alternat Med       Date:  2021-08-20       Impact factor: 2.629

7.  RIPK4 Is an Immune Regulating-Associated Biomarker for Ovarian Cancer and Possesses Generalization Value in Pan-Cancer.

Authors:  Cui Liao; Yi-Xia Zhao; Wei-di Han; Nian-Yu Lai
Journal:  J Immunol Res       Date:  2022-03-09       Impact factor: 4.818

Review 8.  Role of Receptor Interacting Protein (RIP) kinases in cancer.

Authors:  Kaylee Ermine; Jian Yu; Lin Zhang
Journal:  Genes Dis       Date:  2021-11-18

9.  The RIPK family: expression profile and prognostic value in lung adenocarcinoma.

Authors:  Guo Li; Zhijie Xu; Jinwu Peng; Yuanliang Yan; Yong Liu; Xin Zhang; Yuanzheng Qiu; Chencheng Fu
Journal:  Aging (Albany NY)       Date:  2022-07-30       Impact factor: 5.955

Review 10.  Receptor-interacting protein in malignant digestive neoplasms.

Authors:  Lilong Zhang; Wenyi Guo; Jia Yu; Chunlei Li; Man Li; Dongqi Chai; Weixing Wang; Wenhong Deng
Journal:  J Cancer       Date:  2021-05-19       Impact factor: 4.207

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.